We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.59 | 6.00 | 7.18 | - | 78,877 | 08:00:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.75 | 13.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/3/2020 16:37 | The potential market is huge and the sky is the limit for this company if the trial is successful, although may take a while longer than we all would like. | bountyhunter | |
25/3/2020 16:36 | Apparently that is what the company has been suggesting as the likely price.... Don't forget this is a protein drug so is quite expensive to manufacture. It's not like making aspirin... | nobbygnome | |
25/3/2020 16:35 | Nobby If I may say the idea of £1000 a dose is quite frankly absolute bolox (as opposed to botox) There is no way that the company would wish to profiteer (as opposed to make a profit) and the price will be determines by the PPRS in the UK | toffeeman | |
25/3/2020 16:30 | Treatment where it's most effective, blockbuster on the way me thinks | bobaxe1 | |
25/3/2020 16:30 | Calm down tidy it will come when it's ready. Try holding a stock more than a day ffs... | blueblood | |
25/3/2020 16:29 | So one positive aspect to the fund raise is if the trial turns out to be negative. In that circumstance the company will be well funded so the downside will not be as bad as it would have been. And the other thought now they have secured 100% ownership of the drug by this fund raising, this has become an even bigger binary bet. I have seen a few big ones in the past (IMM for example) but this is just going to be massive. I have heard it mentioned that this will cost £1000 a dose and could be used prophylactically as well as a treatment. Just think of that absolutely massive market. I was thinking maybe £500 million post a positive result but now I am thinking more like £1 billion or about £7.50 a share after the dilution. No I am not joking.... | nobbygnome | |
25/3/2020 16:25 | Drug does already work on viruses and Covid support are saying early success for inhalation treatment. SNG001 is the only nebuliser treatment | tidy 2 | |
25/3/2020 16:23 | AmbiorixThat I agree is suspicious...re sale by GriffithsNevertheles | yet another final | |
25/3/2020 16:19 | Shocking... | bountyhunter | |
25/3/2020 16:19 | That comment relating to an article pre dating the current trial is being purposely misconstrued by pumpers | saw89 | |
25/3/2020 16:18 | This is a small raise in the greater scheme of things - the fact that their main investor target is VCT/EIS funds means that they have a minimum three year time horizon of staying independent and so further financing will be a deal with big Pharma on better terms than before. In reality it is all down to whether or not the drug is effective in Covid-19: because if it is, it will likely work in the next wave or the next Coronovirus which comes along. The competitive advantege of SNG001 is that if it works, it can be used in the future before vaccines are available. | toffeeman | |
25/3/2020 16:18 | Never trust degsy or likya | arab3 | |
25/3/2020 16:17 | It’s going to be 2 weeks - 2 months before they are able to start statistically validating the impact of this treatment | saw89 | |
25/3/2020 16:17 | Was posted yesterday the 24th March. Saw, give it a rest. | likya123 | |
25/3/2020 16:16 | You might be underwater but continually posting fake news is totally unfair to those who are believing it | saw89 | |
25/3/2020 16:16 | Tidy2 And that's only the Placebo patients! | thwarnts | |
25/3/2020 16:14 | It is not related to the current trial which is a double bind and therefore the dispenser does not know . Jeez | saw89 | |
25/3/2020 16:14 | We’ve already been clear that the comment relates to an article posted 18th March before the NHS trial started. | saw89 | |
25/3/2020 16:13 | Tidy that’s fake news | saw89 | |
25/3/2020 16:10 | Just found out I'm in!! | bobaxe1 | |
25/3/2020 16:08 | Strap yourselves in | mo2550 | |
25/3/2020 16:07 | I used to hold CIR and a big shareholder there called Richard Griffiths was always getting slagged of,,, must be the same bloke!!!!!!!!!! | mostro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions